(MedPage Today) — CHICAGO — Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in the near future, with results after 1 year reported here from one of its key phase III trials.
Further…
(MedPage Today) — CHICAGO — Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in the near future, with results after 1 year reported here from one of its key phase III trials.
Further…
Cookery schools are booming in northern Thailand, where tourists can learn to prepare classic dishes. Read full story Source: www.thestar.com.my...
India’s encounter with DEG has occurred at multiple points over the past four decades, leaving behind a trail of deaths....
His meeting with Anwar Ibrahim will take place in Putrajaya on Sunday (Feb 8), where they will witness the signing...
Scroll for five minutes and it feels like everyone else has it all — more success, more beauty, more of...
What has the Budget allocated for mental health institutions? Will it be enough to tackle an emergency? Source: www.thehindu.com Medical...
